Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 10 studies | 23% ± 8% | |
| endothelial cell | 9 studies | 24% ± 5% | |
| epithelial cell | 6 studies | 31% ± 13% | |
| glutamatergic neuron | 5 studies | 42% ± 23% | |
| goblet cell | 5 studies | 23% ± 10% | |
| neuron | 4 studies | 26% ± 11% | |
| fibroblast | 4 studies | 31% ± 11% | |
| ciliated cell | 4 studies | 21% ± 6% | |
| macrophage | 4 studies | 18% ± 3% | |
| astrocyte | 4 studies | 29% ± 5% | |
| oligodendrocyte precursor cell | 4 studies | 28% ± 8% | |
| pancreatic A cell | 3 studies | 29% ± 12% | |
| non-classical monocyte | 3 studies | 23% ± 7% | |
| GABAergic neuron | 3 studies | 48% ± 10% | |
| abnormal cell | 3 studies | 20% ± 4% | |
| basal cell | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 6124.65 | 2642 / 2642 | 100% | 90.95 | 705 / 705 |
| breast | 100% | 7276.86 | 459 / 459 | 100% | 67.17 | 1118 / 1118 |
| esophagus | 100% | 8174.38 | 1445 / 1445 | 100% | 42.71 | 183 / 183 |
| pancreas | 100% | 5090.32 | 328 / 328 | 100% | 47.78 | 178 / 178 |
| prostate | 100% | 8088.47 | 245 / 245 | 100% | 73.34 | 502 / 502 |
| stomach | 100% | 6572.97 | 359 / 359 | 100% | 42.98 | 286 / 286 |
| thymus | 100% | 9523.12 | 653 / 653 | 100% | 71.13 | 605 / 605 |
| lung | 100% | 6474.20 | 578 / 578 | 100% | 49.44 | 1154 / 1155 |
| intestine | 100% | 7999.36 | 966 / 966 | 100% | 41.60 | 526 / 527 |
| bladder | 100% | 8748.43 | 21 / 21 | 100% | 40.33 | 503 / 504 |
| ovary | 100% | 8290.06 | 180 / 180 | 100% | 41.18 | 429 / 430 |
| liver | 100% | 3821.58 | 226 / 226 | 100% | 42.30 | 405 / 406 |
| skin | 100% | 7140.41 | 1809 / 1809 | 100% | 70.32 | 470 / 472 |
| uterus | 100% | 9162.45 | 170 / 170 | 100% | 46.79 | 457 / 459 |
| kidney | 100% | 5903.43 | 89 / 89 | 99% | 53.05 | 894 / 901 |
| adrenal gland | 100% | 10000.30 | 258 / 258 | 99% | 57.96 | 228 / 230 |
| adipose | 100% | 7023.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 9239.84 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 37.59 | 29 / 29 |
| spleen | 100% | 5732.78 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 46.03 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 36.43 | 1 / 1 |
| muscle | 100% | 5736.75 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 7157.55 | 854 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 52.02 | 79 / 80 |
| peripheral blood | 90% | 3615.36 | 836 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0050673 | Biological process | epithelial cell proliferation |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0045787 | Biological process | positive regulation of cell cycle |
| GO_0042060 | Biological process | wound healing |
| GO_0005730 | Cellular component | nucleolus |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0030496 | Cellular component | midbody |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | C6orf89 |
| Protein name | Bombesin receptor-activated protein C6orf89 (Amfion) |
| Synonyms | BRAP UNQ177/PRO203 |
| Description | FUNCTION: Exhibits histone deacetylase (HDAC) enhancer properties . May play a role in cell cycle progression and wound repair of bronchial epithelial cells . . |
| Accessions | ENST00000480824.7 [Q6UWU4-1] ENST00000373685.1 [Q6UWU4-1] ENST00000355190.7 [Q6UWU4-2] ENST00000359359.6 [Q6UWU4-3] Q6UWU4 |